About
Reviews
Community
4th Annual Gene Therapy Immunogenicity Summit 2023
05
Sep
-
07
Sep
2023
When
Boston
USA
Where

Developing safe and effective gene therapies using AAV vectors is hindered by challenges related to the immune response. However, over the past two decades, drug developers have identified and are working on solutions to various immune responses to AAV vectors.

The 4th Annual Gene Therapy Immunogenicity Summit is an opportunity for gene therapy drug developers, leading academics, regulators, and service providers to come together to discuss improving risk assessments, monitoring, and mitigating AAV gene therapy immunogenicity.

By registering for the 2023 summit, attendees will have access to keynote speeches by prominent gene therapy figures, in-depth discussions on preclinical and clinical developments, and valuable networking opportunities with more than 150 peers. This summit aims to provide actionable tools, insights, and connections to enhance attendees' work on immunogenicity.

Why Attend

4th Annual Gene Therapy Immunogenicity Summit 2023

Delve into the world of gene therapy immunogenicity.

Grow

Leverage insights from talks and panels, participate in breakout discussions, utilize Q&A time built in to talks, and meet and learn from gene therapy leaders during our dedicated networking sessions.

Experience

Connect with experts, peers, and industry leaders, fostering collaborations, and building relationships that drive innovation in gene therapy immunogenicity research.

Be inspired

Across 3 days of in-depth case studies, new data, and new tech, hear from the likes of Spark Therapeutics, Voyager Therapeutics, Bayer, and AskBio.

Similar Events

You May Like

Event

Hanson Wade
0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.

05 - 07 Sep 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Brian Baker
Sr. Director, Regulatory Affairs (CDx)
Jean Philippe Combal
Co-Founder & Chief Executive Officer
Genevieve Laforet
Vice President, Clinical Development
Klaudia Kuranda
Head of Immunology
Vibha Jawa
Executive Director
Adrian Veres
Chief Scientific Officer (CSO)
Brad Hoffman
Associate Professor of Pediatrics & Neuroscience
Edit Tarcsa
DMPK-BA site head East Coast
Giuseppe Ronzitti
Researcher
Jayoung Kim
Assistant Professor
Jyoti Rana
Research Assistant Professor
Lena Winstedt
Global Franchise Lead Gene Therapy

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Certara

Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development.

Certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development.

Precision For Medicine

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.

Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics.

Organizer

All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.

Get emails from us

Thank you
Oops! Something went wrong